Yonsei University
Clinical trials sponsored by Yonsei University, explained in plain language.
-
New combo therapy shows promise for rare sarcoma
Disease control CompletedThis study tested a combination of the immunotherapy drug durvalumab with standard chemotherapy (doxorubicin) in 44 people with advanced soft tissue sarcoma that had spread or come back. The goal was to see if adding durvalumab could improve outcomes for this aggressive cancer, w…
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New heart stent shows promise in Real-World patients
Disease control CompletedThis study looked at a new type of heart stent (a small mesh tube) that slowly releases medicine to keep arteries open. The stent's coating dissolves over a few months, which may lower the risk of blood clots. Researchers followed 204 people with coronary artery disease for one y…
Sponsor: Yonsei University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New stent shows promise for High-Risk heart patients
Disease control CompletedThis study looked at how safe and effective a new type of drug-coated stent (Genoss) is for people with serious coronary artery disease. Researchers followed 200 patients for a year to track heart-related deaths, heart attacks, and the need for repeat procedures. The goal was to …
Sponsor: Yonsei University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for steroid users: drug may shield stomach from damage
Disease control CompletedThis study tested whether fexuprazan, a new stomach acid reducer, can prevent or control gastritis (stomach inflammation) symptoms in people who need to take systemic steroids for at least 4 weeks. 42 adults with respiratory diseases were randomly assigned to take either fexupraz…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Lower is better? new study tests aggressive cholesterol goals in asian heart patients
Disease control CompletedThis study looked at whether aiming for a very low LDL-cholesterol level (below 55 mg/dL) is better than a standard target (below 70 mg/dL) in people with heart or blood vessel disease. About 3,000 adults in Asia took either a statin alone or a statin plus ezetimibe to lower thei…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Longer heart monitoring catches more hidden irregularities in Stroke-Prone patients
Diagnosis CompletedThis study tested whether wearing a heart monitor for 8 days or more finds more cases of atrial fibrillation (an irregular heartbeat that raises stroke risk) than wearing it for just 1 day. About 1,000 adults aged 75 or older, or with other stroke risk factors, wore the MEMO Patc…
Phase: NA • Sponsor: Yonsei University • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC
-
COPD inhaler boosts exercise capacity in new study
Symptom relief CompletedThis study looked at whether a combination inhaler (tiotropium/olodaterol) can improve exercise ability in people with COPD who have overinflated lungs. 44 adults with COPD used the inhaler for 4 weeks. Researchers measured changes in oxygen use during exercise, heart function, a…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 17, 2026 02:04 UTC
-
Brain zaps for the blues: new study tests tDCS for depression
Symptom relief CompletedThis study tested if a non-invasive brain stimulation technique called tDCS can reduce depression symptoms. 198 adults with mild to moderate depression used a home-based device. The goal was to see if this gentle electrical stimulation could improve mood and daily function.
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 17, 2026 02:01 UTC
-
One-Time radiofrequency treatment lifts jawline in small study
Symptom relief CompletedThis study tested whether one session of radiofrequency with continuous water cooling can improve jawline contour and facial volume in women aged 38 to 50. Twenty-two women participated, and researchers measured changes over 8 weeks using 3D imaging. The goal was to see if this n…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Can a lung drug help obese patients breathe better during surgery?
Symptom relief CompletedThis study looked at whether iloprost, a drug used for high blood pressure in the lungs, can improve oxygen levels in obese patients during one-lung ventilation for lung surgery. 78 adults with a BMI over 30 scheduled for lung surgery took part. The goal was to see if the drug he…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
New skin booster shows promise for wrinkle reduction in small trial
Symptom relief CompletedThis study tested a new skin booster made from human tissue (phADM) combined with hyaluronic acid (HA) against HA alone for improving wrinkles and skin texture. Twenty adults received injections on one side of the face with the combination and on the other side with HA alone. The…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Which wrist artery lowers radiation for heart doctors?
Knowledge-focused CompletedThis study compared how much radiation doctors receive during heart procedures when accessing the heart through the left wrist artery versus the right wrist artery. Over 1,000 patients were included. The goal was to see if the left wrist approach reduces radiation exposure for th…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC
-
Wrist-Based heart procedure shows promise in small study
Knowledge-focused CompletedThis study looked at whether using a slightly larger tube (7-French) through a small wrist artery near the thumb is safe and effective for heart stenting. One hundred adults with heart disease took part. The main goal was to check for bleeding, bruising, or other problems at the …
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC
-
Vitamin d may help red blood cell recovery after heart surgery
Knowledge-focused CompletedThis study looked at 135 adults who had heart bypass surgery to see if vitamin D levels before surgery affect how quickly their hemoglobin (a part of red blood cells) recovers afterward. Researchers also measured a protein called hepcidin, which controls iron in the body. The goa…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Scientists hunt for clues to predict lung cancer drug success
Knowledge-focused CompletedThis study aimed to find biological markers in the blood and tumors that could predict how well patients with advanced non-small cell lung cancer respond to the immunotherapy drug atezolizumab. Researchers analyzed immune cells, genetics, and microbiomes from 100 participants. Th…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Protein clue may explain anemia after heart surgery
Knowledge-focused CompletedThis study looked at 150 adults having planned heart valve surgery to see if a protein called erythroferron is linked to hemoglobin levels after surgery. Researchers measured erythroferron right after surgery and tracked hemoglobin changes over time. The goal was to better unders…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
AI-Powered ECG could predict heart damage from cancer drugs
Knowledge-focused CompletedThis study looked at whether an AI-enhanced electrocardiogram (ECG) can predict heart problems caused by cancer treatments like chemotherapy and immunotherapy. Over 31,000 adults who had an ECG before starting cancer therapy were included. The goal was to see if this simple, low-…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC